Failure of viral oncoproteins to target the p53-homologue p51A

被引:30
作者
Roth, J
Dobbelstein, M
机构
[1] Univ Marburg, Inst Virol, D-35037 Marburg, Germany
[2] Klinikum Univ Marburg, Zentrum Innere Med, D-35043 Marburg, Germany
关键词
D O I
10.1099/0022-1317-80-12-3251
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The p51/p63/KET proteins were identified based on their strong homology to the tumour suppressor p53 and a related set of proteins termed p73, All these protein species were shown to activate transcription from at least some p53-responsive promoters. To evaluate a possible role of the transcriptionally active splicing variant p51A/p63 gamma in tumour suppression, we determined whether viral oncoproteins that inactivate p53 might also target p51A, Neither the large T-antigen of simian vacuolating virus 40 (SV40) nor the E6 protein from human papillomavirus type 18 were found to inhibit p51A-mediated transcription, whereas they strongly suppress the activity of p53, Further, SV40 T-antigen directly interacts with p53 but not detectably with p51A. Finally, a cytoplasmic mutant (K128A) of SV40 T-antigen relocalizes p53 from the nucleus to the cytoplasm, but p51A remains in the nucleus when coexpressed with cytoplasmic T-antigen. These results strongly suggest that the inhibitory effect of these viral oncoproteins is specific for p53 and does not measurably affect p51A. Thus, unlike p53, p51A does not appear to be a necessary target in virus-induced cell transformation and may not exert a role comparable to p53 in tumour suppression.
引用
收藏
页码:3251 / 3255
页数:5
相关论文
共 38 条
  • [21] Cloning and functional analysis of human p51, which structurally and functionally resembles p53
    Osada, M
    Ohba, M
    Kawahara, C
    Ishioka, C
    Kanamaru, R
    Katoh, I
    Ikawa, Y
    Nimura, Y
    Nakagawara, A
    Obinata, M
    Ikawa, S
    [J]. NATURE MEDICINE, 1998, 4 (07) : 839 - 843
  • [22] Prabhu NS, 1998, INT J ONCOL, V13, P5
  • [23] The yeast two-hybrid system reveals no interaction between p73α and SV40 large T-antigen
    Reichelt, M
    Zang, KD
    Seifert, M
    Welter, C
    Ruffing, T
    [J]. ARCHIVES OF VIROLOGY, 1999, 144 (03) : 621 - 626
  • [24] Inactivation of p53 but not p73 by adenovirus type 5 E1B 55-kilodalton and E4 34-kilodalton oncoproteins
    Roth, J
    König, C
    Wienzek, S
    Weigel, S
    Ristea, S
    Dobbelstein, M
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (11) : 8510 - 8516
  • [25] THE E6 ONCOPROTEIN ENCODED BY HUMAN PAPILLOMAVIRUS TYPE-16 AND TYPE-18 PROMOTES THE DEGRADATION OF P53
    SCHEFFNER, M
    WERNESS, BA
    HUIBREGTSE, JM
    LEVINE, AJ
    HOWLEY, PM
    [J]. CELL, 1990, 63 (06) : 1129 - 1136
  • [26] THE HPV-16 E6 AND E6-AP COMPLEX FUNCTIONS AS A UBIQUITIN-PROTEIN LIGASE IN THE UBIQUITINATION OF P53
    SCHEFFNER, M
    HUIBREGTSE, JM
    VIERSTRA, RD
    HOWLEY, PM
    [J]. CELL, 1993, 75 (03) : 495 - 505
  • [27] A novel protein with strong homology to the tumor suppressor p53
    Schmale, H
    Bamberger, C
    [J]. ONCOGENE, 1997, 15 (11) : 1363 - 1367
  • [28] A second p53-related protein, p73L, with high homology to p73
    Senoo, M
    Seki, N
    Ohira, M
    Sugano, S
    Watanabe, M
    Tachibana, M
    Tanaka, T
    Shinkai, Y
    Kato, H
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 248 (03) : 603 - 607
  • [29] Steegenga WT, 1999, MOL CELL BIOL, V19, P3885
  • [30] Sunahara M, 1998, INT J ONCOL, V13, P319